Search Results for 'ethmoid sinus surgery'
-
Intersect ENT Touts Publication of a Pooled Analysis of the SINUVA Sinus Implant for Nasal Polyps
Pooled analysis of the RESOLVE and RESOLVE II studies provides Level 1a clinical evidence.Business Wire 07.23.19
-
Intersect ENT Enrolls First Patient in ASCEND Study of Investigational Drug-Coated Sinus Balloon
Drug-device combination will leverage company’s expertise in localized drug delivery.Business Wire 01.31.19
-
Intersect ENT Launches SINUVA Sinus Implant
New treatment is clinically proven to reduce polyps and symptoms of nasal congestion.Business Wire 05.03.18
-
Study Shows Intersect ENT's SINUVA Significantly Reduces Nasal Obstruction, Improves Sense of Smell
SINUVA expands in the sinus cavity and delivers an anti-inflammatory steroid directly to the site of polyp disease.Business Wire 02.13.18
-
FDA Approves Intersect ENT's SINUVA Sinus Implant
Product offers targeted relief for managing recurrent nasal polyps.Business Wire 01.12.18
